Terms: = Testicular cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Treatment
12 results:
1. Genetics of testicular cancer: a review.
Martin FC; Conduit C; Loveland KL; Thomas B; Lewin J; Tran B
Curr Opin Urol; 2022 Sep; 32(5):481-487. PubMed ID: 35855571
[TBL] [Abstract] [Full Text] [Related]
2. kras and BRAF Mutations in Stage II and III Colon cancer: A Systematic Review and Meta-Analysis.
Formica V; Sera F; Cremolini C; Riondino S; Morelli C; Arkenau HT; Roselli M
J Natl Cancer Inst; 2022 Apr; 114(4):517-527. PubMed ID: 34542636
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy-Refractory testicular Tumors.
Lian B; Zhang W; Wang T; Yang Q; Jia Z; Chen H; Wang L; Xu J; Wang W; Cao K; Gao X; Sun Y; Shao C; Liu Z; Li J
Oncologist; 2019 Dec; 24(12):e1437-e1442. PubMed ID: 31492770
[TBL] [Abstract] [Full Text] [Related]
4. Genetics of testicular germ cell tumors.
Singla N; Lafin JT; Ghandour RA; Kaffenberger S; Amatruda JF; Bagrodia A
Curr Opin Urol; 2019 Jul; 29(4):344-349. PubMed ID: 31045925
[TBL] [Abstract] [Full Text] [Related]
5. New insights into germ cell tumor genomics.
Lafin JT; Bagrodia A; Woldu S; Amatruda JF
Andrology; 2019 Jul; 7(4):507-515. PubMed ID: 30896089
[TBL] [Abstract] [Full Text] [Related]
6. K-RAS and N-RAS mutations in testicular germ cell tumors.
Hacioglu BM; Kodaz H; Erdogan B; Cinkaya A; Tastekin E; Hacibekiroglu I; Turkmen E; Kostek O; Genc E; Uzunoglu S; Cicin I
Bosn J Basic Med Sci; 2017 May; 17(2):159-163. PubMed ID: 28426398
[TBL] [Abstract] [Full Text] [Related]
7. testicular germ cell tumor genomics.
Woldu SL; Amatruda JF; Bagrodia A
Curr Opin Urol; 2017 Jan; 27(1):41-47. PubMed ID: 27584029
[TBL] [Abstract] [Full Text] [Related]
8. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
[TBL] [Abstract] [Full Text] [Related]
9. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
[TBL] [Abstract] [Full Text] [Related]
10. Histopathological and molecular features of late relapses in non-seminomas.
Mayer F; Wermann H; Albers P; Stoop H; Gillis AJ; Hartmann JT; Bokemeyer CC; Oosterhuis JW; Looijenga LH; Honecker F
BJU Int; 2011 Mar; 107(6):936-43. PubMed ID: 20955261
[TBL] [Abstract] [Full Text] [Related]
11. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
[TBL] [Abstract] [Full Text] [Related]
12. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.
Roelofs H; Mostert MC; Pompe K; Zafarana G; van Oorschot M; van Gurp RJ; Gillis AJ; Stoop H; Beverloo B; Oosterhuis JW; Bokemeyer C; Looijenga LH
Am J Pathol; 2000 Oct; 157(4):1155-66. PubMed ID: 11021820
[TBL] [Abstract] [Full Text] [Related]
